Dr. Moriarty is the Principal Investigator and Leader of the Musculoskeletal Infection team at the AO Research Institute Davos in Switzerland. He has extensive expertise in applying preclinical in vivo models to address clinically relevant questions on the problem of fracture-related infection (FRI). A particular interest has been in developing prophylactic and therapeutic strategies against FRI, including those caused by antibiotic-resistant pathogens. He is a scientific editor of the eCM Journal, co-organizer of the eCM conference on orthopedic infection, and guest lecturer at the Department of Health Science and Technology (D-HEST) of the ETH Zurich.